PPT-Fighting antimicrobial resistance

State of play of the veterinary regulatory landscape MarieAnne Barthélemy SIMV Pasteur Paris September 27 2017 Round Table 2  Antibiotic resistance French national action plan Ecoantibio. Easow Chiranjoy Mukhopadhyay PG Shivananda Department of Microbiology Manipal College of Medical Sciences Pokhara Nepal Received January 13 2005 Background objectives Shigellae play an important role as a causative organism of acute gastroenterit JMH House staff Orientation 2012. Lilian Abbo, MD. Assistant Professor Clinical Infectious Diseases. Laura Smith, . PharmD. . Infectious Diseases Clinical Pharmacist. What is Stewardship?. Selection. N. gonorrhoeae. . A Review. INTRODUCTION. Progressive antimicrobial resistance in . Neisseria gonorrhoeae . is an emerging public health threat. The Public Health Agency of Canada (the Agency) released updated recommendations in July 2013 for the diagnosis, treatment, follow-up and reporting of gonorrhea. Presenter. date. Supporting healthcare professionals . in the fight against resistance. Expand the standardized antimicrobial web based PPS at a global scale to collect consistent, valid and comparable antimicrobial prescribing data.. What are antibiotics?. Definition: chemicals produced by one microorganism to kill or inhibit the growth of other microorganisms. Now included the semi-synthetic antibiotics. Effective against bacteria. Regulations. An Environment of Change. Brian Lubbers, DVM, PhD, . DACVCP. Director of Clinical Microbiology. Changing Regulations. Cephalosporin . Extralabel. Use Restriction. FDA Guidance 209. FDA Guidance 213. . Dr Andrea Ammon, ECDC Director, . 27 June 2017, European Parliament. 0. 200. 400. 600. 800. 1000. 1900. 1920. 1940. 1960. 1980. 2000. 1918. Influenza pandemic. 1924. Plague: last human-to-human transmission. An Opportunity for Pharmacy Leadership. Holly Maples, . Pharm.D. .. Associate Professor, . Dept. of Pharmacy Practiced. Jeff & Kathy Lewis Sanders Endowed Chair in Pediatrics. UAMS College of Pharmacy. Ireland. Quarter 1-4 2017. 20. th. June 2018. KEY POINTS, 2017 (General). Increasing numbers of invasive infections in recent . years due to the following pathogens. : . K. . pneumonaie. , . P. . aeruginosa, S. . Ireland. Quarter 1-4 2017. 20. th. June 2018. KEY POINTS, 2017 (General). Increasing numbers of invasive infections in recent . years due to the following pathogens. : . K. . pneumonaie. , . P. . aeruginosa, S. . RESISTANCE Interagency Task Force on Antimicrobial Resistance Co - Chairs: Centers for Disease Control and Prevention Food and Drug Administration National Institutes of Health Participating Agencie s CC – 14/ UNIT - 7. Azidothymidine Antibiotic Resistance. Zidovudine (AZT). A synthetic pyrimidine (thymidine) analogue. AZT is converted to its triphosphate form by cellular thymidine kinase. It binds preferentially to HIV – reverse transcriptase resulting in chain termination. . Andraševiæ AT, Tambiæ T, Kaleniæ S, Jankoviæ V. Surveillance for Antimicrobial Resistance in Croatia. Emerg Infect Dis. 2002;8(1):14-18. https://doi.org/10.3201/eid0801.010143. 1. 1. Antibacterial resistance in ophthalmic infections: a multi-centre analysis across UK care settings//BMC Infectious Diseases.- volume 19, Article number: 768 (2019) . Educational MODULE. November 2020.